Total Payments
$673.27
2024 Payments
$74.82
Companies
18
Transactions
31
Medicare Patients
18,243
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$673.27 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $673.27 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec USA, Inc. | $138.93 | 2 | $0 (2022) |
| Eisai Inc. | $69.44 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $65.26 | 3 | $0 (2023) |
| Seagen Inc. | $65.16 | 4 | $0 (2023) |
| Daiichi Sankyo Inc. | $45.84 | 2 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $41.50 | 3 | $0 (2020) |
| Lilly USA, LLC | $38.29 | 3 | $0 (2020) |
| Mirati Therapeutics, Inc. | $31.81 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $24.24 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $22.64 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74.82 | 3 | Mirati Therapeutics, Inc. ($31.81) |
| 2023 | $146.48 | 7 | Novartis Pharmaceuticals Corporation ($47.86) |
| 2022 | $135.80 | 6 | Seagen Inc. ($47.97) |
| 2021 | $109.38 | 2 | Carl Zeiss Meditec USA, Inc. ($96.86) |
| 2020 | $64.26 | 4 | Daiichi Sankyo Inc. ($22.76) |
| 2019 | $97.36 | 6 | Bayer HealthCare Pharmaceuticals Inc. ($30.20) |
| 2018 | $29.73 | 2 | Novartis Pharmaceuticals Corporation ($17.40) |
| 2017 | $15.44 | 1 | Celgene Corporation ($15.44) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Oncology | ||||||
| 01/30/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $31.81 | General |
| Category: Oncology | ||||||
| 12/27/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $24.72 | General |
| Category: Oncology | ||||||
| 11/14/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Oncology | ||||||
| 11/07/2023 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/29/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Oncology | ||||||
| 08/02/2023 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Oncology | ||||||
| 01/10/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Oncology | ||||||
| 11/29/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $23.12 | General |
| Category: Oncology | ||||||
| 10/11/2022 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Oncology | ||||||
| 08/23/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Oncology | ||||||
| 07/19/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Oncology | ||||||
| 06/14/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Oncology | ||||||
| 06/02/2022 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $42.07 | General |
| 11/15/2021 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $96.86 | General |
| 07/06/2021 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Oncology | ||||||
| 10/26/2020 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/18/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Anemia | ||||||
| 01/30/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug), Nubeqa | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: Oncology | ||||||
| 01/22/2020 | Lilly USA, LLC | CYRAMZA (Drug), VERZENIO | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Oncology | ||||||
| 12/17/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug), Aliqopa | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Oncology | ||||||
| 09/10/2019 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Oncology | ||||||
| 08/16/2019 | HealthMyne, Inc. | HealthMyne (Device) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: PACS Viewer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 53 | 4,335 | 4,415 | $1.1M | $270,157 |
| 2022 | 56 | 4,576 | 4,648 | $1.2M | $301,175 |
| 2021 | 53 | 4,672 | 4,780 | $1.3M | $318,078 |
| 2020 | 51 | 4,660 | 4,813 | $1.4M | $344,690 |
Total Patients
18,243
Total Services
18,656
Medicare Billing
$1.2M
Procedure Codes
302
All Medicare Procedures & Services
302 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 75 | 77 | $306,075 | $88,599 | 28.9% |
| 77067 | Screening mammography | Office | 2023 | 626 | 626 | $283,559 | $66,945 | 23.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 629 | 629 | $67,948 | $29,319 | 43.1% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 71 | 73 | $43,070 | $14,210 | 33.0% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 77 | 77 | $32,571 | $4,975 | 15.3% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 134 | 137 | $26,852 | $3,836 | 14.3% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 60 | 60 | $26,700 | $3,664 | 13.7% |
| 77067 | Screening mammography | Facility | 2023 | 101 | 101 | $17,776 | $3,561 | 20.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 413 | 424 | $17,719 | $3,387 | 19.1% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 48 | 48 | $11,505 | $3,228 | 28.1% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 40 | 40 | $16,759 | $2,840 | 16.9% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 101 | 101 | $11,312 | $2,830 | 25.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 42 | 44 | $17,776 | $2,690 | 15.1% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 364 | 408 | $13,464 | $2,634 | 19.6% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 48 | 48 | $16,312 | $2,532 | 15.5% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 75 | 76 | $8,228 | $2,372 | 28.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 35 | 35 | $10,001 | $1,777 | 17.8% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 34 | 34 | $10,094 | $1,770 | 17.5% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 18 | 18 | $22,420 | $1,742 | 7.8% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 47 | 47 | $9,165 | $1,705 | 18.6% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 39 | 39 | $9,165 | $1,462 | 16.0% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 37 | 37 | $10,693 | $1,455 | 13.6% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 47 | 47 | $7,677 | $1,244 | 16.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 14 | 14 | $5,544 | $1,176 | 21.2% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 33 | 33 | $8,118 | $1,158 | 14.3% |
About Dr. Soledad Griffin, MD
Dr. Soledad Griffin, MD is a Diagnostic Radiology healthcare provider based in Pinehurst, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154378156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Soledad Griffin, MD has received a total of $673.27 in payments from pharmaceutical and medical device companies, with $74.82 received in 2024. These payments were reported across 31 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($673.27).
As a Medicare-enrolled provider, Griffin has provided services to 18,243 Medicare beneficiaries, totaling 18,656 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 302 distinct procedure/service records.
Ad
Practice Information
- Specialty Diagnostic Radiology
- Location Pinehurst, NC
- Active Since 05/27/2006
- Last Updated 08/30/2011
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1154378156
Products in Payments
- Lenvima (Drug) $69.44
- KISQALI (Drug) $47.86
- PADCEV (Biological) $33.53
- KRAZATI (Drug) $31.81
- TUKYSA (Drug) $31.63
- Vitrakvi (Drug) $24.83
- JYNARQUE (Drug) $24.24
- CYRAMZA (Drug) $24.21
- Enhertu (Drug) $23.08
- INJECTAFER (Drug) $22.76
- IMFINZI (Biological) $22.64
- FOTIVDA (Drug) $19.93
- LINZESS (Drug) $18.32
- Tibsovo (Drug) $17.98
- VOTRIENT (Drug) $17.40
- ZEPZELCA (Drug) $17.13
- Aliqopa (Drug) $16.67
- HealthMyne (Device) $16.05
- Abraxane (Drug) $15.44
- ALIMTA (Drug) $14.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Pinehurst
Allen Joseph, Md, MD
Diagnostic Radiology — Payments: $3,239
Diagnostic Radiology $3,239
David Furie, Md, MD
Diagnostic Radiology — Payments: $872.58
Diagnostic Radiology $872.58
Michael Edwards, Md, MD
Diagnostic Radiology — Payments: $810.03
Diagnostic Radiology $810.03
Dr. Glen Toomayan, Md, MD
Diagnostic Radiology — Payments: $713.93
Diagnostic Radiology $713.93
Carolyn Maynor, Md, MD
Diagnostic Radiology — Payments: $674.20
Diagnostic Radiology $674.20
John Roberson, Md, MD
Diagnostic Radiology — Payments: $449.28
Diagnostic Radiology $449.28